Abrham Mulugeta Shares Insights on Tranexamic Acid: Exploring the WHO WOMAN Trial
Abrham Mulugeta, Gynecologist at Tercha General Hospital, shared on LinkedIn:
”Drug review Tranexamic Acid (TXA)
Tranexamic Acid (TXA): Life-Saving Antifibrinolytic in Postpartum Hemorrhage (PPH)
TXA is a synthetic lysine analogue that inhibits fibrinolysis — stabilizing blood clots when every minute counts.
Mechanism:
Inhibits plasminogen activation → prevents fibrin degradation → promotes stable clot formation.
Dose (as per WHO and WOMAN trial):
1 g IV over 10 min, ideally within 3 hours of birth.
Repeat once after 30 min if bleeding continues or restarts.
Indicated for:
Treatment of postpartum hemorrhage (PPH) after vaginal or cesarean delivery.
Other indications according to local guidlines.
Evidence:
WOMAN Trial (Lancet 2017)
> 20 000+ women
→ Early TXA (≤3 h) ↓ maternal death due to bleeding by ~30 %.
Side effects:
Nausea, vomiting, dizziness
Rare: thromboembolic events → use cautiously in patients with active thrombosis
Key akeaway:
TXA reduces maternal mortality when given early alongside standard PPH management (uterotonics, IV fluids, surgical measures).
Timing matters — “The sooner, the stronger the benefit.”’
Stay updated with Hemostasis Today.
-
Apr 8, 2026, 14:42Joshua Muia: The Value of Collaboration and The Importance of Exchanging Ideas Across Institutions
-
Apr 8, 2026, 14:37Gregory Piazza: The Rationale and Methods Behind the New AHA/ACC PE Guidelines Clinical Categories
-
Apr 8, 2026, 14:33Ney Carter Borges: Effectiveness and Safety of Andexanet alfa in Life-Threatening Factor Xa Inhibitor-Associated Bleeding
-
Apr 8, 2026, 14:32IFI Foundation Launches A Youth-Led Stroke Awareness Campaign On World Health Day 2026 – OdishaPlus
-
Apr 8, 2026, 14:24Riccardo Mazza: Do Weight, BMI, and Renal Function Independently Predict Acute Events in NVAF Patients on DOACs?
-
Apr 8, 2026, 14:17Chokri Ben Lamine: Anticoagulation Switching Pearls
-
Apr 8, 2026, 14:13Francisco Chacón-Lozsán: Bleeding on Anticoagulation Is Not a Complication, It’s a Turning Point
-
Apr 8, 2026, 07:32Giulia Simini: Acquired von Willebrand Syndrome and Coagulation Abnormalities in MPN-Associated Thrombocytosis
-
Apr 8, 2026, 07:14Julian Kyoung-Ryul Chun: Join the Discussion at EHRA 2026